packageRitlecitinib

ritlecitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ritlecitinib is a JAK inhibitor medicine used to treat alopecia areata, a condition causing hair loss. It is authorised in the European Union and is an approved, relatively new treatment.

Summary written by glm-5.3-flash from Wikidata Q120487896 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ritlecitinib
ATC codes:L04AF08
DrugBank:DB14924
PubChem CID:118115473
Wikidata:Q120487896
formula:C15H19N5O
molar mass:285.351 g/mol (PubChem CID 118115473)
logP:2.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown